Troy Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Troy Asset Management's PFE Position: Q1 2021 in Review
Troy Asset Management sold out of Pfizer (PFE) in Q1 2021, closing a stake of 33,000 shares — an estimated $1.22M sold.
Troy Asset Management first reported a position in PFE in Q4 2014 and held it in 22 quarters. The position peaked at $1.45M in Q3 2018. 2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.
- Troy Asset Management reported no remaining Pfizer position as of Q1 2021 after selling out during the quarter.
- Troy Asset Management sold 33,000 Pfizer shares in Q1 2021, an estimated $1.22M.
- Troy Asset Management first reported a position in Pfizer in Q4 2014 and held it in 22 quarters.
- Troy Asset Management's Pfizer position peaked at $1.45M in Q3 2018.
- 2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.
Based on Troy Asset Management's 13F filing for Q1 2021, filed 13 May 2021.